Trade Novartis - CHF - NOVN CFD

Add to favourite

97.10

1.78%

1.50

Low: 95.9

High: 98.05

Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:20

Summary
Historical Data

Trading сonditions

Spread

1.50

Long position overnight fee

-0.012201%

Short position overnight fee

-0.010022%

Overnight fee time

22:00 (UTC)

Min traded quantity

0.1

Currency

CHF

Margin

5.00%

Stock exchange

Switzerland

Commission on trade

Key Stats

Prev. Close	95.4
Open	96.15
1-Year Change	6.13%
Day's Range	95.9 - 98.05

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 21, 2025	97.10	1.55	1.62%	95.55	98.15	95.25
Feb 20, 2025	95.40	-0.90	-0.93%	96.30	96.65	95.05
Feb 19, 2025	94.90	-1.10	-1.15%	96.00	96.55	94.90
Feb 18, 2025	95.90	0.45	0.47%	95.45	96.05	94.90
Feb 17, 2025	95.45	0.35	0.37%	95.10	95.60	94.90
Feb 14, 2025	95.15	-1.80	-1.86%	96.95	97.00	94.90
Feb 13, 2025	95.75	-0.15	-0.16%	95.90	97.65	94.90
Feb 12, 2025	95.65	-2.05	-2.10%	97.70	97.80	95.45
Feb 11, 2025	97.20	0.15	0.15%	97.05	97.85	95.55
Feb 10, 2025	95.05	-1.30	-1.35%	96.35	97.30	95.05
Feb 7, 2025	96.80	0.10	0.10%	96.70	97.70	96.40
Feb 6, 2025	97.55	-1.45	-1.46%	99.00	99.15	95.65
Feb 5, 2025	98.10	2.55	2.67%	95.55	98.25	95.55
Feb 4, 2025	95.40	-1.10	-1.14%	96.50	96.80	94.90
Feb 3, 2025	95.45	0.80	0.85%	94.65	96.00	93.50
Jan 31, 2025	95.40	0.20	0.21%	95.20	97.85	94.90
Jan 30, 2025	92.60	-0.15	-0.16%	92.75	93.85	91.85
Jan 29, 2025	93.25	1.35	1.47%	91.90	93.60	91.65
Jan 28, 2025	92.45	-0.70	-0.75%	93.15	93.15	90.80
Jan 27, 2025	92.15	1.40	1.54%	90.75	92.35	90.05

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Novartis - CHF Company profile

Novartis AG (NVS) is a global pharmaceutical company. Founded in 1996 through a merger of Ciba-Geigy and Sandoz, Novartis is headquartered in Basel, Switzerland. The firm has two divisions: Innovative Medicines and Sandoz.

Innovative Medicines offer prescription medicines and create treatments in areas of respiratory, ophthalmology, neuroscience, immunology, hepatology, dermatology, cardiovascular, renal and metabolism.

Sandoz develops, manufactures and markets generic pharmaceuticals and biosimilars. Sandoz products include: Adakveo (crizanlizumab), Afinitor Disperz/Votubia (everolimus) and Arzerra (ofatumumab) for Oncology; and Aimovig (erenumab) for neuroscience.

In 2020, in response to the pandemic, the company collaborated with Molecular Partners to develop ensovibep, a DARPin therapeutic candidate designed for potential use against Covid-19.

The company’s shares have been listed on the New York Stock Exchange (NYSE) since 2000. Novartis AG stock is traded under the ticker symbol NVS. You can track live NVS share value and price history at Capital.com.

Industry:

Pharmaceuticals (NEC)

Lichtstrasse 35
BASEL
BASEL-STADT 4056
CH

News

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target

We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...

18:29, 7 February 2025

Ripple XRP price prediction: Third-party price target

Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com

15:29, 6 February 2025

Apple Store on Fifth Avenue, New York, October 2016

Apple (AAPL) stock price forecast: third-party price target

We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.

11:22, 6 February 2025